FEATURES
Innovation network brings bioprinted medicine closer to reality
Millions of people worldwide are losing their sight waiting for corneal transplants. To end this dependence on donors, researchers are working on 3D-printing replacement corneas from stem cells.
A new multimillion-euro international research network has been set up to accelerate...
Diabetes: a protective gel for a future without insulin injections
By developing an innovative gel, UNIGE and HUG researchers have achieved a major breakthrough toward a bioartificial pancreas.
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type...
Living ‘tumour on a chip’ could give best insight into aggressive brain cancer
Scientists are creating a glioblastoma ‘tumour on a chip’– a tiny living system capable of mimicking the key features of the human brain and providing a deeper understanding of how the aggressive brain cancer works.
It is hoped that the...
Growing sustainable rubber from dandelions
A Norwich-based biotech firm is developing sustainable natural rubber from specially engineered dandelions.
QuberTech recently raised £3.4 million in combined grant funding and equity investment to accelerate development of its engineering biology platform and scale commercial operations.
The funding backs QuberTech’s...
Implantable tech could cast new light on bladder cancer treatment
A new implantable device which aims to maximise the effectiveness of light-sensitive drugs could improve future outcomes for bladder cancer patients.
Engineers and cancer scientists from the University of Glasgow have developed the device, which uses wirelessly powered micro-LEDs to...
Manchester team powers next-gen enzyme engineering
A University of Manchester techbio spin-out has secured £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next-gen enzyme engineering.
Imperagen has raised a total of £8.5m to accelerate R&D, expand wet lab capabilities, and...
World first: genome loaded onto quantum computer
Scientists have achieved a world first by loading a complete genome onto a quantum computer – a major step towards using quantum computing to tackle some of biology’s most complex bioinformatic challenges.
The breakthrough comes from a collaboration between...
Delivering versatility without complexity in medical technology
In laboratory instruments, linear motion is where precision meets practicality. Whether positioning a pipette, advancing a fluid, or moving a sample through a preparation workflow, designers need motion that is accurate, repeatable, and dependable over long duty cycles. At...
Why high performance cultures break down under pressure in bioscience organisations
High performance in bioscience organisations rarely breaks down because people aren’t capable. It breaks down when scientific, regulatory and commercial pressure increases, but the systems supporting performance don’t evolve with it. What looks like a talent or execution issue...
A growing bioscience cluster – built for innovation, scale & impact
As the UK’s life sciences sector continues to grow, businesses are increasingly looking for environments that offer more than just laboratory space. Access to talent, specialist infrastructure, research expertise and opportunities for collaboration are becoming critical factors in supporting...
Redefining the future of surgery
Nerve repair demands complex microsurgical suturing skills. Maria Pereira, co-founder of TISSIUM, explains how biomorphic materials are changing the landscape of surgical repair.
For decades, we have tried to repair the human body with materials and solutions that don’t heal...
Injectable gel could help repair damaged swallowing muscles
Biomaterial increases stem cell survival fivefold in preclinical tests, paving the way for advances in regenerative treatments.
A new injectable gel developed by researchers at McGill University and Kyoto University could enable stem cell-based treatments for swallowing disorders.
While stem...
Coral surface behaviour offers insights into physics of infertility and ovarian cancer
A new study could hold the key to understanding the causes of long-term health problems, such as infertility and ovarian cancer.
The study, published in Physics Review X Life, used a combination of high-resolution imaging, flow measurements, and mathematical modelling to examine...
Study of millions of cells unveils new understanding of genetic risk
Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease.
Published in Nature, the research carried out at the Wellcome...
UK biotech launches world-first lab-grown human muscle platform to transform drug testing
A Loughborough University spin-out has developed advanced human muscle models designed to more accurately replicate how medicines behave in the human body. The aim is to accelerate drug development and reduce reliance on animal testing.
Myomaker Bio is set to...
Beyond biopsies: new methods of collecting data for dermatology research
Théo Boyer, project manager at Indero, explores how novel methodologies could influence the collection of biological data in future clinical research.
Dermatology trials frequently rely on blood draws and skin biopsies to evaluate inflammatory pathways, pharmacodynamic activity and drug exposure.
While...
Middle East disruption is affecting global clinical trials
Analysis of 65,000+ trials and 350,000+ sites show thousands of studies affected, with Phase III trials most exposed.
Analysis of 65,061 globally recruiting clinical trials across 186 countries has found that 4,361 studies - equivalent to 6.7% of all active...
New UK framework for advanced therapy clinical trials
A new national framework designed to support the standardisation and expansion of advanced therapy clinical trials has launched.
The Advanced Therapy Clinical Trials Capability Framework, produced jointly by the Advanced Therapy Treatment Centre (ATTC) network, the Cell and Gene...
Phage therapy hopes for cystic fibrosis patients
Researcher Dr Jessica Lewis has been awarded a share of £1.3 million in funding to explore bacteriophage treatments for people with cystic fibrosis.
The funding, from Cystic Fibrosis Trust, will enable her to investigate whether new combinations of bacteriophage could...
Proton beam therapy could transform mesothelioma treatment
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with the rare and aggressive cancer of the lining of the lung.
The HIT-MESO...
Chemically ‘stapled’ peptides used to target difficult-to-treat cancers
Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilise, and test millions of potential drug molecules inside living cells, making it much quicker and easier to discover new treatments for...
Why chronic pain lasts longer in women: Immune cells offer clues
Pain is influenced by sex hormones such as testosterone, a Michigan State University study has discovered.
Chronic pain lasts longer for women than men, and new research has found that differences in hormone-regulated immune cells, called monocytes, may help explain...
Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals 2026
Taking place at the Coventry Building Society Arena on 21-22 April 2026 and free to attend, Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals are co-located events providing professionals from across pharmaceutical and nutraceutical supply chains with a platform for...
Why business resilience is crucial for the bioscience sector
Bioscience businesses operate in one of the most complex and highly regulated risk environments in the global economy. Innovation cycles are long, regulation is exacting, and the consequences of disruption – whether to research, laboratory processes, manufacturing, or supply...
Early signs of Parkinson’s identified in blood
A team led by researchers at Chalmers University of Technology, Sweden, has identified biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage occurs.
The biological processes leave measurable traces in the blood, but only for a limited...
New test could help pinpoint IBD diagnosis
A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests.
Scientists have developed a tool to measure the activity of a molecule linked to...
Discovering why only some early tumours survive could help spot cancer at earliest stages
Cambridge scientists have shown that when tumours first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.
The study, carried out in mice and further validated...
Successful ALS treatments are a $143bn opportunity to change lives
Huge advances have been made in our understanding of neurodegenerative diseases – but ALS still has no cure and new investment is urgently needed. By Dr Amanda Cole, Director, Office of Health Economics (OHE).
LS, the most common form of...
World-first AI model launch for programmable gene insertion
The breakthrough – by biotech Basecamp Research – aims to tackle a longstanding challenge in genetic medicine by developing a new generation of curative cell & gene therapies.
These first AI models, capable of programmable gene insertion, offer a new...
How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest...
